Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial

Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial

Introduction The COVID-19 pandemic caused by the virus SARS-CoV has spread rapidly and caused damage worldwide. Data suggest a major overrepresentation of hypertension and diabetes among patients experiencing severe courses of COVID-19 including COVID-19-related deaths. Many of these patients receiv...

Full description

Bibliographic Details
Main Authors: Pradeesh Sivapalan, Jens-Ulrik Stæhr Jensen, Filip Krag Knop, Tina Vilsbøll, Mikkel Bring Christensen, Vivian Kliim-Hansen, Lærke Smidt Gasbjerg, Anne-Marie Ellegaard, Hans Johan Niklas Lorentsson, Mads Bank Lynggaard, Christoffer Andersen Hagemann, Christian Legart, David Siersbæk Mathiesen
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/11/e062895.full

Internet

https://bmjopen.bmj.com/content/12/11/e062895.full

Similar Items